Improved ICU Outcomes With Protocolized Management of Analgesia, Sedation and Delirium

This study has been completed.
Sponsor:
Information provided by:
Maisonneuve-Rosemont Hospital
ClinicalTrials.gov Identifier:
NCT00506649
First received: July 23, 2007
Last updated: NA
Last verified: July 2007
History: No changes posted
  Purpose

To assess pain, agitation, and delirium experienced by critically ill patients daily and evaluate the impact of a protocol; to compare the incidence of coma and delirium, length of stay, mortality and costs of care between pre- and post-protocol groups.


Condition Intervention
Critical Care
Other: protocol

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Official Title: Comparison of no Protocol vs Protocolized Approach to Pain, Sedation and Delirium Management in the ICU

Resource links provided by NLM:


Further study details as provided by Maisonneuve-Rosemont Hospital:

Enrollment: 1214
Study Start Date: August 2003
Study Completion Date: November 2005
Intervention Details:
    Other: protocol
    management protocols of non-pharmacological strategies and individualized titration of analgesics, sedatives, and anti-psychotics based on observed scores to manage sedation, analgesia and delirium.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All adult patients admitted to ICU

Exclusion Criteria:

  • Repeat admission within the same hospitalisation; moribund patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00506649

Locations
Canada, Quebec
Hopital Maisonneuve Rosemont
Montreal, Quebec, Canada, H1T 2M4
Sponsors and Collaborators
Maisonneuve-Rosemont Hospital
Investigators
Principal Investigator: Yoanna Skrobik, MD FRCP(c) Maisonneuve-Rosemont Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00506649     History of Changes
Other Study ID Numbers: 007
Study First Received: July 23, 2007
Last Updated: July 23, 2007
Health Authority: Canada':'Ethics Review Committee'

Keywords provided by Maisonneuve-Rosemont Hospital:
protocol
analgesia
sedation
delirium
coma

Additional relevant MeSH terms:
Delirium
Confusion
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders

ClinicalTrials.gov processed this record on July 28, 2014